Code intelligence

Z13.88 reimbursement alerts

Policy changes, MAC LCD updates, and CMS guidance matched to code Z13.88.

Normal code riskView ICD-10 detail

Signal breakdown

3 shown · 3 total in platform

Risk: Normal

Critical

High

Routine

100%

Low

New this month

—

alerts added in last 30 days

Effective soon

—

no upcoming deadlines

LCD L40197 (Notice Ends 08/09/2026): MolDX: Biomarker Testing in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis — Noridian

Policy LCD-L40197 · Clinical Laboratory

Routine

New LCD governs MASLD/MASH biomarker testing starting Aug 2026.

View alert

LCD L40187 (Notice Ends 08/09/2026): MolDX: Biomarker Testing in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis — Palmetto GBA

Policy LCD-L40187 · Clinical Laboratory

Routine

New MolDX LCD for MASLD/MASH biomarker tests effective Aug 2026.

View alert

LCD L38435: MolDX: Pharmacogenomics Testing — WPS

Policy LCD-L38435 · Clinical Laboratory

Routine

New billing guidelines for Pharmacogenomics Testing effective 2025.

View alert

Audit documentation

Building an audit file that includes Z13.88?

The Tripwire Audit Pack exports 12 months of Clinical Laboratory policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.

Get the Clinical Laboratory audit pack — $349One-time purchase · not a subscription